"All roads lead to medication?" Qualitative responses from an Australian first-person survey of antipsychotic discontinuation

Psychiatric Rehabilitation Journal

Volumn 36, Issue 3, 2013, Pages 160-165

  Salomon, Carmela ^a   Hamilton, Bridget ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

antipsychotic agents; health communication; medication noncompliance; substance withdrawal syndrome

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; AUSTRALIA; COOPERATION; DECISION MAKING; DOCTOR PATIENT RELATION; FEMALE; HEALTH SURVEY; HUMAN; MALE; MEDICATION COMPLIANCE; MENTAL DISEASE; MIDDLE AGED; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; WITHDRAWAL SYNDROME; MENTAL DISORDERS; PSYCHOLOGY;

ADULT; ANTIPSYCHOTIC AGENTS; AUSTRALIA; COOPERATIVE BEHAVIOR; DECISION MAKING; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MEDICATION ADHERENCE; MENTAL DISORDERS; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; QUALITATIVE RESEARCH; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84897364972     PISSN: 1095158X     EISSN: None     Source Type: Journal    
DOI: 10.1037/prj0000001     Document Type: Article

References (28)

1. Barnes, T. R. (2011). Evidence-based guidelines for the pharmacological treatment of schizophrenia: Recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 25, 567-620. doi:10.1177/0269881110391123
2. Bola, J. R. (2006). Medication-free research in early episode schizophrenia: Evidence of long-term harm? Schizophrenia Bulletin, 32, 288-296. doi:10.1093/schbul/sbj019
3. Calton, T., Ferriter, M., Huband, N., & Spandler, H. (2008). A systematic review of the Soteria paradigm for the treatment of people diagnosed with schizophrenia. Schizophrenia Bulletin, 34, 181-192. doi:10.1093/schbul/ sbm047
4. Cheung, Y. W. (2000). Substance abuse and developments in harm reduction. Canadian Medical Association Journal, 162, 1697-1700.
5. Chue, P. (2006). The relationship between patient satisfaction and treatment outcomes in schizophrenia. Journal of Psychopharmacology, 20, 38-56. doi:10.1177/1359786806071246
6. Conley, R. R., Kelly, D. L., Lambert, T. J., & Love, R. C. (2005). Comparison of clozapine use in Maryland and in Victoria, Australia. Psychiatric Services, 56, 320-323. doi:10.1176/appi.ps.56.3.320
7. Deegan, P. E., & Drake, R. E. (2006). Shared decision making and medication management in the recovery process. Psychiatric Services, 57, 1636-1639. doi:10.1176/appi.ps.57.11.1636
8. Gitlin, M., Nuechterlein, K., Subotnik, K. L., Ventura, J., Mintz, J., Fogelson, G.,. Aravagiri, M. (2001). Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. The American Journal of Psychiatry, 158, 1835-1842. doi: 10.1176/appi.ajp.158.11. 1835
9. Gray, R., Leese, M., Bindman, J., Becker, T., Burti, L., David, A.,. Tansella, M. (2006). Adherence therapy for people with schizophrenia: European multicentre randomised controlled trial. The British Journal of Psychiatry, 189, 508-514. doi:10.1192/bjp.bp.105.019489
10. Harrow, M., & Jobe, T. H. (2007). Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: A 15-year multifollow-up study. Journal of Nervous and Mental Disease, 195, 406-414.
11. Haynes, R. B., Ackloo, E. S., Sahota, N., McDonald, H. P., & Yao, X. (2008). Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews (Online), 2, CD000011.
12. Jablensky, A. (2000). Epidemiology of schizophrenia: The global burden of disease and disability. European Archives of Psychiatry and Clinical Neuroscience, 250, 274-285. doi:10.1007/s004060070002
13. Karnieli-Miller, O., & Eisikovits, Z. (2009). Physician as partner or salesman? Shared decision-making in real-time encounters. Social Science & Medicine, 69, 1-8. doi:10.1016/j.socscimed.2009.04.030
14. Kulhara, P., & Chakrabarti, S. (2001). Culture and schizophrenia and other psychotic disorders. Psychiatric Clinics of North America, 24, 449-464. doi:10.1016/S0193-953X(05)70240-9
15. Malekinejad, M., Johnston, L. G., Kendall, C., Kerr, L. R. F. S., Rifkin, M. R., & Rutherford, G. W. (2008). Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: A systematic review. AIDS and Behavior, 12, S105-S130. doi:10.1007/s10461-008-9421-1
16. McIntosh, A. M., Conlon, L., Lawrie, S. M., & Stanfield, A. C. (2010). Compliance therapy for schizophrenia. Cochrane Database of Systematic Reviews (Online), 3, CD003442.
17. Moncrieff, J. (2006). Why is it so difficult to stop psychiatric drug treatment? It may be nothing to do with the original problem. Medical Hypotheses, 67, 517-523. doi:10.1016/j.mehy.2006.03.009
18. Moncrieff, J., & Leo, J. (2010). A systematic review of the effects of antipsychotic drugs on brain volume. Psychological Medicine, 40, 1409-1422. doi:10.1017/S0033291709992297
19. Morrison, A. P., Hutton, P., Shiers, D., & Turkington, D. (2012). Antip-sychotics: Is it time to introduce patient choice? The British Journal of Psychiatry, 201, 83-84. doi:10.1192/bjp.bp.112.112110
20. Novick, D., Haro, J. M., Suarez, D., Perez, V., Dittmann, R. W., & Haddad, P. M. (2010). Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Research, 176, 109-113. doi:10.1016/j.psychres.2009.05.004
21. Read, J. (2009). Psychiatric drugs: Key issues and service user perspectives. New York, NY: Palgrave Macmillan.
22. Roe, D., Goldblatt, H., Baloush-Klienman, V., Swarbrick, M., & Davidson, L. (2009). Why and how people decide to stop taking prescribed psychiatric medication: Exploring the subjective process of choice. Psychiatric Rehabilitation Journal, 33, 38-46. doi:10.2975/33.1.2009.38.46
23. Salomon, C., & Hamilton, B. (2012). Antipsychotic discontinuation syndromes: A narrative review of the evidence and its integration into Australian mental health nursing textbooks. International Journal of Mental Health Nursing. Advance online publication. Retrieved from. doi:10.1111/j.1447- 0349.2012.00889.x
24. Salomon, C., Hamilton, B., & Elsom, S. (2012). Experiences of antipsy-chotic discontinuation: Results from a survey of Australian consumers. Manuscript under review.
25. Scottish Association for Mental Health. (2004). All you need to know? Scottish survey of peoples experiences of psychiatric drugs. Glasgow, Scotland: Scottish Association for Mental Health. Retrieved from http://www.psychmind.co. uk/news/news2004/april04/allyouneedtoknow.pdf
26. Viguera, A. C., Baldessarini, R. J., Hegarty, J., Van Krammen, D. P., & Tohen, M. (1997). Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Archives of General Psychiatry, 54, 49-55. doi:10.1001/archpsyc.1997.01830130055011
27. Weinmann, S., Read, J., & Aderhold, V. (2009). Influence of antipsychot-ics on mortality in schizophrenia: Systematic review. Schizophrenia Research, 113, 1-11. doi:10.1016/j.schres.2009.05.018
28. Woltmann, E. M., & Whitley, R. (2010). Shared decision making in public mental health care: Perspectives from consumers living with severe mental illness. Psychiatric Rehabilitation Journal, 34, 29-36. doi: 10.2975/34.1.2010.29.36